Pharmaceutical drug manufacturing
Active 2017–2026.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | UPSTREAM CONSULTING |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2026 | UPSTREAM CONSULTING |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2025 | UPSTREAM CONSULTING |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | UPSTREAM CONSULTING |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2025 | UPSTREAM CONSULTING |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2025 | UPSTREAM CONSULTING |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2024 | UPSTREAM CONSULTING |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2024 | UPSTREAM CONSULTING |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2024 | UPSTREAM CONSULTING |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2024 | UPSTREAM CONSULTING |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Amount |
|---|---|---|
| UPSTREAM CONSULTING | 38 | $775,000 |
| Issue | Activities |
|---|---|
| Health Issues | 37 |
| Food Industry (safety, labeling, etc.) | 16 |
| Medical/Disease Research/Clinical Labs | 1 |